cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA723618 | parathyroid gland, parathyroid tumor | .e-u | 2206 to 2579 | 378 to 5 | 374/378 (98 %) | 0 diff (100 %id) | |||
AA771701 | parathyroid gland, parathyroid tumor | .e-u | 2179 to 2579 | 404 to 4 | 401/404 (99 %) | 0 diff (100 %id) | |||
AA782502 | parathyroid gland, parathyroid tumor | .e-u | 2238 to 2576 | 351 to 13 | AAA | 339/339 (100 %) | 1 diff (99.8 %id) | ||
AJ420528 | .c | 871 to 2887 | 10 to 2026 | AAA | 2017/2026 (99 %) | 4 diff (99.9 %id) | |||
AJ420597 | .c | 1778 to 2887 | 1 to 1109 | AAA | 1109/1109 (100 %) | 8 diff (99.3 %id) | |||
AK055462 | brain | .c | 1053 to 2887 | 1 to 1835 | available from FLJ, | 1835/1835 (100 %) | 3 diff (99.9 %id) | ||
AK095973 | .b | 1 to 2547 | 1 to 2547 | N57D | tiling clone, available from FLJ, | 2547/2547 (100 %) | 3 diff (99.9 %id) | ||
AK098194 | .c | 415 to 2887 | 1 to 2473 | F24L | tiling clone, available from FLJ, | 2473/2473 (100 %) | 4 diff (99.9 %id) | ||
AW390343 | stomach | .a | 846 to 1312 | 466 to 1 | 466/466 (100 %) | 14 diff (97.0 %id) | |||
AW798386 | uterus | .j | 76 to 254 | 12 to 192 | 181/198 (91 %) | 4 diff (98.0 %id) | |||
AW798395 | uterus | .j | 79 to 220 | 14 to 158 | 145/158 (91 %) | 8 diff (95.0 %id) | |||
AW798617 | uterus | .e-u | 1922 to 2150 | 1 to 229 | 229/236 (97 %) | 2 diff (99.2 %id) | |||
AW801323 | uterus | .e-u | 1897 to 2267 | 1 to 371 | 371/371 (100 %) | 6 diff (98.4 %id) | |||
AW969342 | .e-u | 2323 to 2576 | 262 to 11 | Submitted on the opposite strand | 252/293 (86 %) | 0 diff (100 %id) | |||
AW969346 | .e-u | 1867 to 2431 | 571 to 1 | Submitted on the opposite strand | 571/580 (98 %) | 46 diff (92.1 %id) | |||
AW969372 | .e-u | 1918 to 2579 | 662 to 1 | Submitted on the opposite strand | 662/662 (100 %) | 0 diff (100 %id) | |||
BC035671 | Brain, hippocampus | .a | 54 to 2029 | 1 to 1976 | tiling clone, available from MGC, AAA | 1976/1976 (100 %) | 1 diff (100.0 %id) | ||
BE068835 | breast | .a | 1127 to 1383 | 1 to 257 | 257/257 (100 %) | 3 diff (98.9 %id) | |||
BE068836 | breast | .a | 1163 to 1383 | 1 to 219 | 219/219 (100 %) | 7 diff (96.9 %id) | |||
BE073152 | breast | .j | 1 to 306 | 306 to 1 | tiling clone, | Submitted on the opposite strand | 306/306 (100 %) | 0 diff (100 %id) | |
BE176835 | head_neck | .e-u | 1897 to 2391 | 6 to 500 | 495/500 (99 %) | 11 diff (97.8 %id) | |||
BE176837 | head_neck | .e-u | 1899 to 2391 | 16 to 508 | 493/514 (95 %) | 10 diff (98.1 %id) | |||
BE176981 | head_neck | .e-u | 1949 to 2382 | 1 to 434 | 434/443 (97 %) | 23 diff (94.9 %id) | |||
BE177024 | head_neck | .e-u | 1921 to 2391 | 1 to 471 | 471/471 (100 %) | 13 diff (97.3 %id) | |||
BE177027 | head_neck | .e-u | 1958 to 2382 | 1 to 427 | 427/437 (97 %) | 23 diff (94.8 %id) | |||
BF086926 | head_neck | .i | 1 to 439 | 449 to 14 | V2G F51S | tiling clone, | 436/451 (96 %) | 6 diff (98.7 %id) | |
BF331266 | breast | .a | 1124 to 1383 | 1 to 260 | 260/260 (100 %) | 6 diff (97.7 %id) | |||
BF740455 | bocio_tumor | .b | 1292 to 1684 | 14 to 406 | 393/406 (96 %) | 9 diff (97.8 %id) | |||
BF825585 | head_normal | .j | 181 to 567 | 408 to 21 | G46E D55R I56H S57Q Q58S ... | tiling clone, | Submitted on the opposite strand | 388/408 (95 %) | 0 diff (100 %id) |
BG654711 | Pancreas, Purified pancreatic islet | .e-u | 2083 to 2579 | 497 to 1 | Submitted on the opposite strand | 497/497 (100 %) | 1 diff (99.8 %id) | ||
BG654909 | Pancreas, Purified pancreatic islet | .c | 1987 to 2104 | 1 to 118 | 118/118 (100 %) | 4 diff (96.7 %id) | |||
BI324930 | Pancreas, Purified pancreatic islet | .e-u | 2109 to 2578 | 470 to 1 | 470/470 (100 %) | 0 diff (100 %id) | |||
DA078493 | cerebellum | .b | 1714 to 2277 | 2 to 566 | capped | 565/565 (100 %) | 5 diff (99.2 %id) | ||
DA139196 | alzheimer cortex | .b | 1759 to 2291 | 2 to 534 | tiling clone, capped | 533/533 (100 %) | 0 diff (100 %id) | ||
DA181281 | amygdala | .c | 762 to 1330 | 2 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | ||
DA365602 | subthalamic nucleus | .b | 1755 to 2323 | 2 to 571 | capped | 570/570 (100 %) | 2 diff (99.7 %id) | ||
BX108857 | uterus | .c | 1981 to 2639 | 1 to 659 | 659/659 (100 %) | 0 diff (100 %id) | |||
CN392959 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e-u | 1957 to 2575 | 1 to 619 | 619/619 (100 %) | 4 diff (99.4 %id) | |||
CN392960 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 1644 to 2217 | 1 to 575 | 575/575 (100 %) | 2 diff (99.7 %id) | |||
CN404610 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 692 to 1343 | 1 to 652 | 652/652 (100 %) | 0 diff (100 %id) | |||
CN404611 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 31 to 324 | 1 to 294 | 294/294 (100 %) | 1 diff (99.7 %id) | |||
CN404612 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1152 to 1499 | 1 to 348 | 348/348 (100 %) | 0 diff (100 %id) | |||
CN404613 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 815 to 1500 | 1 to 686 | 686/686 (100 %) | 3 diff (99.6 %id) | |||
CN404614 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .c | 719 to 1428 | 1 to 710 | 710/710 (100 %) | 0 diff (100 %id) | |||
CR749448 | Prostate | .g | 1 to 3581 | 1 to 3581 | exact | tiling clone, available from DKFZ, AAA | 3581/3581 (100 %) | 4 diff (99.9 %id) | |
BX355226 | Neuroblastoma Cot 50-normalized | .e-u | 2179 to 2579 | 1 to 401 | 401/401 (100 %) | 4 diff (99.1 %id) | |||
BX373071 | Placenta Cot 25-normalized | .c | 1425 to 1837 | 423 to 14 | 410/445 (92 %) | 0 diff (100 %id) | |||
BX345014 | Placenta Cot 25-normalized | .a | 78 to 763 | 1 to 686 | 686/686 (100 %) | 3 diff (99.6 %id) | |||
BX360286 | Placenta Cot 25-normalized | .c | 1820 to 2824 | 1030 to 33 | tiling clone, | 998/1027 (97 %) | 10 diff (99.1 %id) | ||
BX360287 | Placenta Cot 25-normalized | .a | 81 to 763 | 1 to 683 | 683/683 (100 %) | 2 diff (99.8 %id) | |||
DA435850 | tongue, tumor tissue | .e-u | 158 to 734 | 2 to 578 | tiling clone, capped | 577/577 (100 %) | 0 diff (100 %id) | ||
DB313384 | tongue, tumor tissue | .e-u | 2040 to 2576 | 537 to 1 | 537/537 (100 %) | 0 diff (100 %id) | |||
DA479333 | .h | 1 to 569 | 2 to 570 | exact | tiling clone, capped | 569/569 (100 %) | 0 diff (100 %id) | ||
AL045008 | testis | .g | 971 to 1285 | 1 to 315 | tiling clone, | 315/315 (100 %) | 0 diff (100 %id) | ||
AL048059 | uterus | .g | 1206 to 1844 | 1 to 639 | tiling clone, | 639/639 (100 %) | 0 diff (100 %id) | ||
AL048089 | uterus | .g | 1206 to 1712 | 1 to 506 | 506/506 (100 %) | 9 diff (98.3 %id) | |||
BX952731 | .m-u | 1 to 701 | 1 to 703 | A5T T21A | tiling clone, | 703/703 (100 %) | 7 diff (99.1 %id) | ||
DA517097 | brain | .c | 1054 to 1591 | 2 to 540 | capped | 539/539 (100 %) | 2 diff (99.7 %id) | ||
DB316916 | brain | .c | 2369 to 2887 | 519 to 1 | 519/519 (100 %) | 1 diff (99.9 %id) | |||
D59313 | .e-u | 2241 to 2576 | 331 to 1 | 331/331 (100 %) | 6 diff (98.2 %id) | ||||
DB458205 | testis | .f | 1 to 477 | 2 to 478 | exact | tiling clone, | 478/478 (100 %) | 0 diff (100 %id) | |
DB523702 | testis | .e-u | 2133 to 2576 | 1 to 444 | Submitted on the opposite strand | 444/444 (100 %) | 1 diff (99.8 %id) | ||
DB459871 | testis | .q | 1 to 448 | 1 to 449 | V2I | tiling clone, | 449/449 (100 %) | 2 diff (99.6 %id) | |
DB525315 | testis | .c | 1443 to 1883 | 1 to 441 | Submitted on the opposite strand | 441/441 (100 %) | 1 diff (99.8 %id) | ||
DB525556 | testis | .e-u | 2132 to 2576 | 1 to 445 | Submitted on the opposite strand | 445/445 (100 %) | 2 diff (99.6 %id) | ||
DB461563 | testis | .a | 25 to 519 | 1 to 495 | 495/495 (100 %) | 1 diff (99.8 %id) | |||
DA578971 | .c | 632 to 1185 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | |||
DA580600 | .b | 2 to 560 | 2 to 561 | capped | 560/561 (99 %) | 2 diff (99.7 %id) | |||
DB318999 | .b | 2012 to 2547 | 536 to 1 | 536/536 (100 %) | 2 diff (99.7 %id) | ||||
N22751 | melanocyte | .e-u | 1945 to 2576 | 632 to 1 | 632/632 (100 %) | 10 diff (98.5 %id) | |||
W04619 | parathyroid gland, parathyroid tumor | .c | 2450 to 2890 | 459 to 4 | 456/464 (98 %) | 0 diff (100 %id) | |||
W31518 | parathyroid gland, parathyroid tumor | .c | 1480 to 1906 | 1 to 430 | 430/430 (100 %) | 7 diff (98.4 %id) | |||
W45579 | senescent fibroblast | .e-u | 1839 to 2396 | 1 to 572 | tiling clone, | 572/587 (97 %) | 18 diff (97.0 %id) | ||
AA026810 | uterus | .c | 1981 to 2495 | 1 to 516 | fully sequenced, | 516/516 (100 %) | 3 diff (99.5 %id) | ||
AA026871 | uterus | .c | 2482 to 2888 | 412 to 1 | tiling clone, fully sequenced, | 412/412 (100 %) | 5 diff (98.8 %id) | ||
AA400528 | .l | 811 to 1183 | 375 to 3 | tiling clone, | 373/375 (99 %) | 0 diff (100 %id) | |||
AA400694 | .l | 1 to 506 | 1 to 507 | F7L | tiling clone, | 507/507 (100 %) | 3 diff (99.5 %id) | ||
AA431749 | .e-u | 2375 to 2579 | 205 to 1 | 205/205 (100 %) | 1 diff (99.6 %id) | ||||
AA470837 | colon | .e-u | 2165 to 2577 | 412 to 1 | 412/412 (100 %) | 4 diff (99.1 %id) | |||
AA570058 | colon | .e-u | 2130 to 2576 | 462 to 16 | AAA | 447/447 (100 %) | 0 diff (100 %id) | ||
AI299997 | carcinoid, lung | .e-u | 2179 to 2576 | 432 to 35 | AAA | 398/398 (100 %) | 3 diff (99.3 %id) | ||
AI275669 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .e-u | 2270 to 2579 | 314 to 4 | 311/314 (99 %) | 0 diff (100 %id) | |||
AI423986 | brain, glioblastoma (pooled) | .e-u | 2143 to 2576 | 433 to 1 | 433/433 (100 %) | 4 diff (99.1 %id) | |||
AI492223 | B-cell, chronic lymphotic leukemia | .e-u | 2128 to 2576 | 460 to 12 | AAA | 449/449 (100 %) | 1 diff (99.8 %id) | ||
AI523699 | Prostate | .e-u | 2102 to 2579 | 478 to 1 | 478/478 (100 %) | 1 diff (99.8 %id) | |||
AI801290 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .e-u | 2129 to 2579 | 451 to 2 | 450/451 (99 %) | 0 diff (100 %id) | |||
AI568958 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .e-u | 2199 to 2579 | 385 to 5 | 381/385 (98 %) | 0 diff (100 %id) | |||
AI584143 | adenocarcinoma, Pancreas | .e-u | 2242 to 2577 | 336 to 1 | 336/336 (100 %) | 1 diff (99.8 %id) | |||
AI805619 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .e-u | 2103 to 2576 | 473 to 1 | 473/476 (99 %) | 2 diff (99.6 %id) | |||
AI912501 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .e-u | 2110 to 2579 | 472 to 3 | 470/472 (99 %) | 0 diff (100 %id) | |||
AI672550 | pooled germ cell tumors | .e-u | 2072 to 2582 | 511 to 1 | tiling clone, | 511/511 (100 %) | 0 diff (100 %id) | ||
AI654485 | pooled germ cell tumors | .e-u | 2102 to 2579 | 481 to 4 | 478/481 (99 %) | 0 diff (100 %id) | |||
AI701793 | pooled | .c | 1605 to 1888 | 293 to 5 | 289/293 (98 %) | 0 diff (100 %id) | |||
AI867398 | colon, colon tumor, RER+ | .e-u | 2200 to 2579 | 381 to 1 | 381/381 (100 %) | 2 diff (99.5 %id) | |||
AI866358 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .e-u | 2278 to 2576 | 299 to 1 | 299/363 (82 %) | 3 diff (99.2 %id) | |||
AI935615 | Kidney | .a | 1551 to 1959 | 412 to 1 | tiling clone, | 412/412 (100 %) | 19 diff (95.4 %id) | ||
AI992301 | pooled germ cell tumors | .e-u | 2235 to 2582 | 348 to 1 | 348/348 (100 %) | 2 diff (99.5 %id) | |||
AI968039 | pooled germ cell tumors | .e-u | 2043 to 2582 | 540 to 1 | 540/540 (100 %) | 2 diff (99.7 %id) | |||
AI968060 | pooled germ cell tumors | .e-u | 2073 to 2582 | 511 to 1 | 511/511 (100 %) | 2 diff (99.7 %id) | |||
AW517037 | cervix | .c | 1802 to 2172 | 370 to 1 | 370/371 (99 %) | 1 diff (99.8 %id) | |||
AW341443 | pooled | .e-u | 2209 to 2573 | 370 to 6 | 365/370 (98 %) | 0 diff (100 %id) | |||
AW515775 | pooled germ cell tumors | .e-u | 2054 to 2574 | 529 to 9 | 521/529 (98 %) | 0 diff (100 %id) | |||
BF221704 | Prostate | .e-u | 2113 to 2577 | 465 to 1 | 465/465 (100 %) | 1 diff (99.8 %id) | |||
BE736971 | adenocarcinoma, Pancreas | .e-u | 1940 to 2574 | 1 to 635 | 635/638 (99 %) | 2 diff (99.7 %id) | |||
BE783277 | eye, retinoblastoma | .c | 1119 to 1851 | 1 to 725 | 725/725 (100 %) | 18 diff (97.6 %id) | |||
BF529913 | anaplastic oligodendroglioma with 1p/19qloss, brain | .c | 1383 to 2057 | 12 to 687 | tiling clone, | 676/687 (98 %) | 6 diff (99.2 %id) | ||
BG257635 | embryonal carcinoma, cell line, testis | .b | 1512 to 2325 | 1 to 805 | 805/894 (90 %) | 27 diff (97.0 %id) | |||
BG699412 | brain, hippocampus | .a | 48 to 107 | 1 to 60 | 60/60 (100 %) | 3 diff (95.0 %id) | |||
BI755268 | brain | .c | 1359 to 2124 | 1 to 767 | 767/768 (99 %) | 6 diff (99.3 %id) | |||
BI912961 | brain | .c | 1223 to 1944 | 1 to 721 | 721/727 (99 %) | 12 diff (98.4 %id) | |||
BM805721 | brain, hippocampus | .a | 54 to 746 | 129 to 828 | 700/1150 (60 %) | 20 diff (98.3 %id) | |||
BM558496 | duodenal adenocarcinoma, cell line, small intestine | .a | 365 to 1384 | 1 to 1029 | 1027/1031 (99 %) | 37 diff (96.5 %id) | |||
BQ021671 | lung, Metastatic Chondrosarcoma | .e-u | 1905 to 2576 | 689 to 19 | AAA | 671/671 (100 %) | 3 diff (99.6 %id) | ||
BM996157 | lung, Metastatic Chondrosarcoma | .e-u | 1917 to 2576 | 678 to 19 | AAA | 660/660 (100 %) | 2 diff (99.7 %id) | ||
BU177739 | adenocarcinoma, Pancreas | .a | 948 to 1670 | 1 to 729 | 727/961 (75 %) | 13 diff (98.7 %id) | |||
BQ931858 | eye, normal pigmented retinal epithelium | .a | 101 to 609 | 1 to 514 | 514/1411 (36 %) | 24 diff (98.3 %id) | |||
BU561074 | testis | .r | 1 to 379 | 1 to 381 | exact | tiling clone, | 381/919 (41 %) | 11 diff (98.9 %id) | |
CX782221 | human embryonic stem cells | .e-u | 1940 to 2576 | 666 to 30 | AAA | 637/637 (100 %) | 2 diff (99.7 %id) | ||
CX782290 | human embryonic stem cells | .e-u | 1 to 770 | 1 to 770 | tiling clone, | 770/770 (100 %) | 1 diff (99.9 %id) | ||
CX753515 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .c | 1507 to 2247 | 1 to 734 | tiling clone, | Submitted on the opposite strand | 734/836 (87 %) | 8 diff (99.1 %id) | |
CB988462 | Human Placenta, placenta | .a | 97 to 835 | 30 to 770 | 741/770 (96 %) | 9 diff (98.9 %id) | |||
CB961220 | Human Placenta, placenta | .a | 1 to 609 | 29 to 637 | 609/835 (72 %) | 8 diff (99.1 %id) | |||
CB959630 | Human Placenta, placenta | .a | 1 to 739 | 29 to 775 | 747/790 (94 %) | 14 diff (98.3 %id) | |||
CD110061 | Human Placenta, placenta | .a | 97 to 744 | 30 to 685 | 656/802 (81 %) | 17 diff (97.9 %id) | |||
CB960471 | Human Placenta, placenta | .a | 1 to 763 | 29 to 795 | tiling clone, | 767/798 (96 %) | 15 diff (98.2 %id) | ||
CD109068 | brain, Pituitary | .a | 62 to 897 | 26 to 867 | 842/913 (92 %) | 26 diff (97.2 %id) | |||
CF593883 | Human Placenta, placenta | .a | 1 to 691 | 30 to 732 | 701/810 (86 %) | 24 diff (97.1 %id) | |||
CF785931 | mixed | .a | 713 to 1477 | 8 to 771 | 764/839 (91 %) | 17 diff (98.0 %id) | |||
TI_57215453 | .c | 1359 to 2124 | 34 to 800 | 767/801 (95 %) | 6 diff (99.3 %id) | ||||
TI_57199295 | .d | 1 to 724 | 22 to 751 | A2D P3L A7C E8R E9G ... | tiling clone, | 730/753 (96 %) | 20 diff (97.4 %id) | ||
TI_57238429 | .c | 1217 to 1944 | 24 to 750 | 727/756 (96 %) | 16 diff (97.9 %id) | ||||
TI_44349577 | .a | 51 to 753 | 79 to 781 | 703/781 (90 %) | 17 diff (97.9 %id) | ||||
DA655264 | .n | 1 to 572 | 2 to 573 | F7S | tiling clone, capped | 572/572 (100 %) | 2 diff (99.7 %id) | ||
NM_173674.1 | .a | 54 to 2029 | 1 to 1976 | RefSeq, AAA | 1976/1976 (100 %) | 1 diff (100.0 %id) | |||
BM797426 | stomach | .e-u | 2456 to 2576 | 1 to 118 | AAA | 118/118 (100 %) | 7 diff (94.1 %id) | ||
BM818207 | stomach | .e-u | 2451 to 2576 | 3 to 128 | AAA | 126/128 (98 %) | 6 diff (95.4 %id) | ||
TI_1948137018 | .a | 178 to 760 | 130 to 711 | 582/1403 (41 %) | 14 diff (99.1 %id) | ||||
TI_1948137019 | .a | 178 to 1107 | 128 to 1057 | 930/1302 (71 %) | 34 diff (97.4 %id) | ||||
TI_1948137020 | .b | 771 to 1661 | 1035 to 130 | 908/1116 (81 %) | 16 diff (98.6 %id) | ||||
TI_1948137021 | .b | 808 to 1661 | 1000 to 141 | 862/1442 (59 %) | 38 diff (97.4 %id) | ||||
TI_1948137356 | .a | 178 to 762 | 125 to 709 | 585/1481 (39 %) | 16 diff (99.0 %id) | ||||
TI_1948137357 | .a | 178 to 1058 | 129 to 1016 | 888/1323 (67 %) | 21 diff (98.5 %id) | ||||
TI_1948137358 | .a | 939 to 1794 | 989 to 130 | 861/1090 (78 %) | 10 diff (99.1 %id) | ||||
TI_1948137359 | .a | 939 to 1794 | 997 to 141 | 858/1394 (61 %) | 25 diff (98.3 %id) | ||||
TI_1948137704 | .a | 178 to 694 | 127 to 642 | 516/1357 (38 %) | 15 diff (98.9 %id) | ||||
TI_1948137705 | .a | 178 to 1105 | 124 to 1047 | 924/1270 (72 %) | 30 diff (97.7 %id) | ||||
TI_1948137706 | .a | 898 to 1795 | 1026 to 129 | 900/1075 (83 %) | 9 diff (99.2 %id) | ||||
TI_1948138054 | .a | 178 to 694 | 128 to 643 | 516/1398 (36 %) | 19 diff (98.7 %id) | ||||
TI_1948138055 | .a | 178 to 1124 | 128 to 1089 | 962/1359 (70 %) | 40 diff (97.1 %id) | ||||
TI_1948138056 | .a | 938 to 1795 | 992 to 129 | 866/1085 (79 %) | 9 diff (99.2 %id) | ||||
TI_1948138057 | .a | 1149 to 1795 | 788 to 139 | 652/1433 (45 %) | 8 diff (99.5 %id) | ||||
DA946666 | Spleen | .c | 1151 to 1732 | 2 to 589 | capped | 588/588 (100 %) | 6 diff (99.0 %id) | ||
DA990181 | synovial membrane tissue from rheumatioidarthritis | .a | 381 to 909 | 2 to 531 | capped | 530/530 (100 %) | 1 diff (99.9 %id) | ||
DR004722 | placenta | .a | 42 to 532 | 27 to 517 | 491/518 (94 %) | 7 diff (98.7 %id) | |||
DB046760 | testis | .c | 1153 to 1719 | 2 to 569 | capped | 568/568 (100 %) | 2 diff (99.7 %id) | ||
DB068779 | testis | .c | 1 to 543 | 2 to 544 | tiling clone, capped | 543/543 (100 %) | 0 diff (100 %id) | ||
DB078510 | testis | .p | 1 to 476 | 2 to 478 | exact | tiling clone, capped | 477/477 (100 %) | 5 diff (99.0 %id) | |
DB085634 | testis | .k | 1 to 564 | 2 to 565 | exact | tiling clone, to resequence, capped | 564/564 (100 %) | 2 diff (99.7 %id) | |
DB341106 | testis | .k | 1280 to 1800 | 521 to 1 | tiling clone, to resequence, | 521/521 (100 %) | 2 diff (99.7 %id) | ||
DB093549 | testis | .a | 38 to 604 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
DB094099 | testis | .o | 1 to 539 | 2 to 540 | exact | tiling clone, capped | 539/539 (100 %) | 1 diff (99.9 %id) | |
TI_149277463 | .e-u | 1878 to 2576 | 789 to 92 | AAA | 698/699 (99 %) | 2 diff (99.8 %id) | |||
BU677689 | lung | .e-u | 1898 to 2576 | 696 to 19 | AAA | 678/678 (100 %) | 2 diff (99.8 %id) | ||
BU624005 | cell lines, Enchondroma | .e-u | 1966 to 2576 | 629 to 19 | AAA | 611/611 (100 %) | 1 diff (99.9 %id) | ||
BU615199 | Bone, Human Chondrosarcoma Cell Line | .e-u | 1826 to 2576 | 763 to 19 | tiling clone, AAA | 745/746 (99 %) | 7 diff (99.1 %id) | ||
CB529889 | Aveolar Macrophage, lung | .c | 1305 to 1883 | 594 to 19 | AAA | 576/576 (100 %) | 6 diff (99.0 %id) | ||
DB246774 | .a | 1210 to 1773 | 2 to 566 | capped | 565/565 (100 %) | 2 diff (99.7 %id) | |||
DB260210 | uterus | .b | 1717 to 2281 | 2 to 566 | capped | 565/565 (100 %) | 3 diff (99.5 %id) | ||
BF871665 | lung_tumor | .a | 51 to 753 | 79 to 781 | This clone was ignored | 703/781 (90 %) | 17 diff (97.9 %id) | ||
DB217785 | trachea | .n | 1 to 572 | 2 to 573 | tiling clone, capped | This clone was ignored | 572/572 (100 %) | 2 diff (99.7 %id) | |
DB349208 | trachea | .a | 54 to 2029 | 1 to 1976 | RefSeq, | This clone was ignored | 1976/1976 (100 %) | 1 diff (100.0 %id) | |
DB262151 | uterus | .e-u | 2456 to 2576 | 1 to 118 | capped | This clone was ignored | 118/118 (100 %) | 7 diff (94.1 %id) | |
DB351695 | uterus | .e-u | 2451 to 2576 | 3 to 128 | This clone was ignored | 126/128 (98 %) | 6 diff (95.4 %id) | ||
TI_1948137018 | .a | 178 to 760 | 130 to 711 | 582/1403 (41 %) | 14 diff (99.1 %id) | ||||
TI_1948137019 | .a | 178 to 1107 | 128 to 1057 | 930/1302 (71 %) | 34 diff (97.4 %id) | ||||
TI_1948137020 | .b | 771 to 1661 | 1035 to 130 | 908/1116 (81 %) | 16 diff (98.6 %id) | ||||
TI_1948137021 | .b | 808 to 1661 | 1000 to 141 | 862/1442 (59 %) | 38 diff (97.4 %id) | ||||
TI_1948137356 | .a | 178 to 762 | 125 to 709 | 585/1481 (39 %) | 16 diff (99.0 %id) | ||||
TI_1948137357 | .a | 178 to 1058 | 129 to 1016 | 888/1323 (67 %) | 21 diff (98.5 %id) | ||||
TI_1948137358 | .a | 939 to 1794 | 989 to 130 | 861/1090 (78 %) | 10 diff (99.1 %id) | ||||
TI_1948137359 | .a | 939 to 1794 | 997 to 141 | 858/1394 (61 %) | 25 diff (98.3 %id) | ||||
TI_1948137704 | .a | 178 to 694 | 127 to 642 | 516/1357 (38 %) | 15 diff (98.9 %id) | ||||
TI_1948137705 | .a | 178 to 1105 | 124 to 1047 | 924/1270 (72 %) | 30 diff (97.7 %id) | ||||
TI_1948137706 | .a | 898 to 1795 | 1026 to 129 | 900/1075 (83 %) | 9 diff (99.2 %id) | ||||
TI_1948138054 | .a | 178 to 694 | 128 to 643 | 516/1398 (36 %) | 19 diff (98.7 %id) | ||||
TI_1948138055 | .a | 178 to 1124 | 128 to 1089 | 962/1359 (70 %) | 40 diff (97.1 %id) | ||||
TI_1948138056 | .a | 938 to 1795 | 992 to 129 | 866/1085 (79 %) | 9 diff (99.2 %id) | ||||
TI_1948138057 | .a | 1149 to 1795 | 788 to 139 | 652/1433 (45 %) | 8 diff (99.5 %id) | ||||
DA946666 | Spleen | .c | 1151 to 1732 | 2 to 589 | capped | 588/588 (100 %) | 6 diff (99.0 %id) | ||
DA990181 | synovial membrane tissue from rheumatioidarthritis | .a | 381 to 909 | 2 to 531 | capped | 530/530 (100 %) | 1 diff (99.9 %id) | ||
DR004722 | placenta | .a | 42 to 532 | 27 to 517 | 491/518 (94 %) | 7 diff (98.7 %id) | |||
DB046760 | testis | .c | 1153 to 1719 | 2 to 569 | capped | 568/568 (100 %) | 2 diff (99.7 %id) | ||
DB068779 | testis | .c | 1 to 543 | 2 to 544 | tiling clone, capped | 543/543 (100 %) | 0 diff (100 %id) | ||
DB078510 | testis | .p | 1 to 476 | 2 to 478 | exact | tiling clone, capped | 477/477 (100 %) | 5 diff (99.0 %id) | |
DB085634 | testis | .k | 1 to 564 | 2 to 565 | exact | tiling clone, to resequence, capped | 564/564 (100 %) | 2 diff (99.7 %id) | |
DB341106 | testis | .k | 1280 to 1800 | 521 to 1 | tiling clone, to resequence, | 521/521 (100 %) | 2 diff (99.7 %id) | ||
DB093549 | testis | .a | 38 to 604 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
DB094099 | testis | .o | 1 to 539 | 2 to 540 | exact | tiling clone, capped | 539/539 (100 %) | 1 diff (99.9 %id) | |
TI_149277463 | .e-u | 1878 to 2576 | 789 to 92 | AAA | 698/699 (99 %) | 2 diff (99.8 %id) | |||
BU677689 | lung | .e-u | 1898 to 2576 | 696 to 19 | AAA | 678/678 (100 %) | 2 diff (99.8 %id) | ||
BU624005 | cell lines, Enchondroma | .e-u | 1966 to 2576 | 629 to 19 | AAA | 611/611 (100 %) | 1 diff (99.9 %id) | ||
BU624005 | cell lines, Enchondroma | .e-u | 1966 to 2576 | 629 to 19 | AAA | 611/611 (100 %) | 1 diff (99.9 %id) | ||
BU615199 | Bone, Human Chondrosarcoma Cell Line | .e-u | 1826 to 2576 | 763 to 19 | tiling clone, AAA | 745/746 (99 %) | 7 diff (99.1 %id) | ||
BU615199 | Bone, Human Chondrosarcoma Cell Line | .e-u | 1826 to 2576 | 763 to 19 | tiling clone, AAA | 745/746 (99 %) | 7 diff (99.1 %id) | ||
CB529889 | Aveolar Macrophage, lung | .c | 1305 to 1883 | 594 to 19 | AAA | 576/576 (100 %) | 6 diff (99.0 %id) | ||
CB529889 | Aveolar Macrophage, lung | .c | 1305 to 1883 | 594 to 19 | AAA | 576/576 (100 %) | 6 diff (99.0 %id) | ||
DB246774 | .a | 1210 to 1773 | 2 to 566 | capped | 565/565 (100 %) | 2 diff (99.7 %id) | |||
DB260210 | uterus | .b | 1717 to 2281 | 2 to 566 | capped | 565/565 (100 %) | 3 diff (99.5 %id) |